Virtus ETF Advisers LLC - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 85 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q3 2021$97,000
-50.3%
42,259
-5.0%
0.04%
-46.2%
Q2 2021$195,000
-59.3%
44,471
-32.6%
0.08%
-60.4%
Q1 2021$479,000
+71.1%
66,007
+1.8%
0.20%
+74.1%
Q4 2020$280,000
+68.7%
64,838
+60.9%
0.12%
+33.3%
Q3 2020$166,000
-39.6%
40,292
-12.0%
0.09%
-33.1%
Q2 2020$275,000
+25.6%
45,787
+57.3%
0.13%
+44.4%
Q1 2020$219,000
-52.3%
29,107
-12.8%
0.09%
+20.0%
Q4 2019$459,000
+122.8%
33,365
+92.1%
0.08%
+78.6%
Q3 2019$206,000
-19.5%
17,366
-5.3%
0.04%
-22.2%
Q2 2019$256,00018,3330.05%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders